Long‐Term Efficacy and Safety of Triple‐Combination Therapy With Olmesartan Medoxomil and Amlodipine Besylate and Hydrochlorothiazide for Hypertension

J Clin Hypertens (Greenwich). 2012;14:149–157. ©2012 Wiley Periodicals, Inc. Most patients with hypertension require combination therapy in order to achieve blood pressure (BP) goals. This 40‐week open‐label extension of the 12‐week double‐blind Triple Therapy With Olmesartan Medoxomil, Amlodipine,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Clin Hypertens (Greenwich)
Glavni autori: Kereiakes, Dean J., Chrysant, Steven G., Izzo, Joseph L., Littlejohn, Thomas, Oparil, Suzanne, Melino, Michael, Lee, James, Fernandez, Victor, Heyrman, Reinilde
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2012
Teme:
Original Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8108825/
https://ncbi.nlm.nih.gov/pubmed/22372774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00588.x
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items